A new blood-brain barrier(BBB) model : Specific uses under in vitro conditions of brain diseases
A new blood-brain barrier(BBB) model : Specific uses under in vitro conditions of brain diseases
批准号:
18590236
负责人:
NIWA Masami
金额:
$2.57万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
以大鼠原代脑内皮细胞、星形胶质细胞和周细胞为材料,构建单培养、双培养和三共培养7种不同类型的血脑屏障模型。通过测量小分子量标记荧光素的跨内皮电阻和通透性来比较模型的屏障完整性。我们可以证实单培养的脑内皮单层不形成紧密的屏障。在共培养条件下,周细胞对荧光素的电阻比I型星形细胞高,通透性比I型星形细胞低。在三重共培养模型中,当内皮细胞和周细胞位于插入物多孔过滤膜的两侧,星形胶质细胞位于培养皿(BBB kit)的底部时,观察到最紧密的屏障。利用BBBkit,我们研究了在体外prion蛋白片段PrP106-126、amyloid-B肽(1-42)和缺氧(BBB kit疾病模型)刺激下,中枢作用药物对血脑屏障的影响和通透性。依达拉奉是一种临床广泛使用的抗脑水肿药物,可显著保护短暂性脑缺血引起的血脑屏障破坏。PPS是一种朊病毒疾病的候选药物,在PrP106-126下,PPS在血脑屏障上的渗透速度更快。西洛他唑增加缺氧和组胺作用下脑水肿体外模型血脑屏障试剂盒p -糖蛋白活性。因此,我们的血脑屏障检测试剂盒是病理条件下研究血脑屏障药物通透性的合适体外实验工具。
英文摘要
Seven different types of blood-brain barrier(BBB)models, mono-culture, double and triple co-cultures, were constructed from primary rat brain endothelial cells, astrocytes and pericytes on culture inserts. The barrier integrity of the models were compared by measurement of transendothelial electrical resistance and permeability for the small molecular weight marker fluorescein. We could confirm that brain endothelial monolayers in mono-culture do not form tight barrier. Pericytes induced higher electrical resistance and lower permeability for fluorescein than type I astrocytes in co-culture conditions. In triple co-culture models the tightest barrier was observed when endothelial cells and pericytes were positioned on the two sides of the porous filter membrane of the inserts and astrocytes at the bottom of the culture dish(BBB kit). With the BBBkit, we investigated effects and permeability on the BBB of centrally acting drugs under in vitro stimulations of prion protein fragment PrP106-126, amyloid-B peptide(1-42), and hypoxia(BBB kit disease models).Edaravone, a clinically-widely used anti-brain edema drug, markedly defended the BBB disruption due to a transient cerebral ischemia. PPS, a candidate drug for prion disease, penetrated more rapidly on the BBB under PrP106-126. Cilostazol increased the activity of P-glycoprotein of the BBB kit under hypoxia and histamine, an in vitro model of the brain edema. Thus, our BBB kit was found to be a suitable in vitro-experimental tool to study drug-permeability on the BBB under pathological conditions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Inhibition of transforming growth factors-B production in brain pericytes contributes to cyclosporin A-induced dysfunction of the blood-blain barrier
抑制脑周细胞中转化生长因子-B 的产生导致环孢菌素 A 诱导的血脑屏障功能障碍
DOI:
--
发表时间:
2007
期刊:
Cell Mol Neurobiol 27
影响因子:
--
作者:
[Takata, F., Dohgu, S., Yamauchi, A., Sumi, N., Nakagawa, S., Naito, M., Tsuruo, T., Shuto, H., Kataoka, Y]
通讯作者:
Y
DOI:
10.1016/j.brainres.2006.09.066
发表时间:
2006-12-06
期刊:
BRAIN RESEARCH
影响因子:
2.9
作者:
[Kobayashi, Hideyuki, Yokoo, Hiroki, Wada, Akihiko]
通讯作者:
Wada, Akihiko
Functional role of the C terminus of human organic anion transporter hOAT1.
人有机阴离子转运蛋白 hOAT1 C 末端的功能作用。
DOI:
10.1074/jbc.m605664200
发表时间:
2006
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Xu,Wen, Tanaka,Kunihiko, Sun,An-qiang, You,Guofeng]
通讯作者:
You,Guofeng
Comparison of the interaction of human organic anion transporter hOAT4 with PDZ proteins between kidney cells and placental cells.
人有机阴离子转运蛋白 hOAT4 与肾细胞和胎盘细胞之间 PDZ 蛋白相互作用的比较。
DOI:
10.1007/s11095-007-9359-4
发表时间:
2008
期刊:
Pharmaceutical research
影响因子:
3.7
作者:
[Zhou,Fanfan, Xu,Wen, Tanaka,Kunihiko, You,Guofeng]
通讯作者:
You,Guofeng
Determination of the external loops and the cellular orientation of the N-and C-termini of the human organic anion transporter hOAT1
人有机阴离子转运蛋白 hOAT1 的外部环路和 N 端和 C 端细胞方向的测定
DOI:
--
发表时间:
2007
期刊:
Bioehem J 401
影响因子:
--
作者:
[Hong, M., Tanaka, K., Pan, Z., Ma, J., You, G]
通讯作者:
G
共 7 条
In vitro blood-brain barrier reconstruction model (BBB Kit) and their application to the functional analysis
-
批准号:22590243
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2010
-
负责人:NIWA Masami
-
依托单位:
Experimental-therapeutic potency of pentosan pofysulfate as an anti-prion and anti-dementia drug
-
批准号:15390081
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.86万
-
财政年份:2003
-
负责人:NIWA Masami
-
依托单位:
In vitro model of the blood-brain barrier
-
批准号:12557009
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.86万
-
财政年份:2000
-
负责人:NIWA Masami
-
依托单位:
Microglial activation protects ischemia-related blood-brain barrier dysfunction
-
批准号:11670092
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1999
-
负责人:NIWA Masami
-
依托单位:
Microglial activation and blood-brain barrier function in ischemia-related neuronal death
-
批准号:09670095
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.98万
-
财政年份:1997
-
负责人:NIWA Masami
-
依托单位:
A new research technique with the computerized radioluminographic imaging-plate system for receptors of neurotransmitters
-
批准号:07557094
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.1万
-
财政年份:1995
-
负责人:NIWA Masami
-
依托单位:
Receptors for Growth Factors in Capillaries Isolated from Human Glioblastomas and Meningiomas
-
批准号:06671401
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.15万
-
财政年份:1994
-
负责人:NIWA Masami
-
依托单位:
Analysis for specific binding sites of endothelins
-
批准号:03670107
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.28万
-
财政年份:1991
-
负责人:NIWA Masami
-
依托单位: